Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.65B | 3.54B | 3.09B | 3.38B | 2.68B | Gross Profit |
1.74B | 1.71B | 1.42B | 1.42B | 1.20B | EBIT |
552.49M | 610.64M | 519.06M | 532.75M | 651.38M | EBITDA |
893.87M | 913.55M | 794.03M | 795.27M | 787.26M | Net Income Common Stockholders |
460.80M | 530.43M | 448.06M | 468.13M | 557.24M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.66B | 1.08B | 960.11M | 1.57B | 1.74B | Total Assets |
6.85B | 6.50B | 5.48B | 5.01B | 5.01B | Total Debt |
1.32B | 1.27B | 568.45M | 233.87M | 123.93M | Net Debt |
492.04M | 190.04M | -391.66M | -1.34B | -1.62B | Total Liabilities |
2.80B | 2.54B | 1.70B | 1.33B | 1.36B | Stockholders Equity |
4.03B | 3.97B | 3.78B | 3.67B | 3.65B |
Cash Flow | Free Cash Flow | |||
403.85M | 966.59M | 273.38M | 282.47M | 511.94M | Operating Cash Flow |
527.30M | 1.10B | 653.69M | 598.55M | 773.29M | Investing Cash Flow |
-306.29M | -1.21B | -1.18B | -280.05M | -190.78M | Financing Cash Flow |
-471.60M | 227.99M | -90.43M | -482.92M | -590.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $72.11B | 11.02 | 13.65% | 7.36% | -5.28% | -13.15% | |
76 Outperform | €4.42B | 8.84 | 11.39% | 8.88% | 1.38% | -14.80% | |
75 Outperform | $129.09B | 18.23 | 20.60% | 2.90% | 14.60% | 24.66% | |
66 Neutral | HK$85.31B | 44.96 | 6.14% | 2.52% | 7.63% | -24.23% | |
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
50 Neutral | HK$492.25M | 9.37 | 3.77% | ― | -11.44% | 111.76% | |
46 Neutral | HK$417.77M | ― | -7.76% | ― | 4.07% | -9.63% |
China Lilang Ltd. announced that all proposed ordinary resolutions at its Annual General Meeting held on April 30, 2025, were approved by shareholders. Key resolutions included the approval of financial statements, declaration of dividends, re-election of directors, and granting mandates for share issuance and repurchase, reflecting strong shareholder support and strategic alignment for future growth.
China Lilang Ltd. reported a high-single-digit growth in retail sales for its LILANZ products in the first quarter of 2025 compared to the same period in 2024. This operational update, based on preliminary unaudited data, suggests a positive trend in the company’s retail performance, though stakeholders are advised to exercise caution as the data is subject to change.
China Lilang Ltd. has announced its upcoming annual general meeting scheduled for April 30, 2025, in Hong Kong. Key agenda items include the approval of the 2024 financial statements, declaration of dividends, re-election of directors, and re-appointment of KPMG as auditors. Additionally, the meeting will consider resolutions to authorize the board to issue new shares, potentially impacting the company’s capital structure and market positioning.
China Lilang Limited announced its audited consolidated results for the year ended 31 December 2024, highlighting compliance with the Hong Kong Stock Exchange’s listing rules. The announcement underscores the company’s strong market presence in the menswear industry in China, potentially reinforcing its position and offering insights into its operational performance and strategic direction.
China Lilang Limited has announced a final cash dividend of HKD 0.09 per share for the financial year ending December 31, 2024. The ex-dividend date is set for May 6, 2025, with the payment date scheduled for May 22, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may influence investor sentiment positively.
China Lilang Ltd. has announced a special cash dividend of HKD 0.03 per share for the financial year ending December 31, 2024. This announcement reflects the company’s strong financial performance and commitment to returning value to its shareholders, potentially enhancing its market position and investor confidence.